✦ LIBER ✦

Alemtuzumab for Steroid Refractory Acute Graft Versus Host Disease in Pediatric Patients: A Retrospective Review of 12 Patients Reveals a Response Rate of 83%

✍ Scribed by P. Khandelwal; A.H. Filipovich; P. Mehta; S. Jodele; M.S. Grimley; K. Myers; M.B. Jordan; A. Kumar; J.J. Bleesing; S.M. Davies; R.A. Marsh

Book ID: 116283241
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 69 KB
Volume: 18
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2011.12.431

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preliminary Results From a Single Instit

Preliminary Results From a Single Institutional Prospective Study of Alemtuzumab for the Treatment of Steroid Refractory Acute Graft Versus Host Disease in Pediatrics

✍ Khandelwal, Pooja; Filipovich, Alexandra; Davies, Stella; Jordan, Michael; Blees 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 82 KB

PMD6 Extracorporeal Photopheresis for th

PMD6 Extracorporeal Photopheresis for the Treatment of Patients With Acute or Chronic Graft Versus Host Disease (GvHD), Refractory to Corticosteroids – A Sytematic Review

✍ J. Walczak; K. Miernik; I. Kuter; M. Ussowicz 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

Prochymal Improves Response Rates In Pat

Prochymal Improves Response Rates In Patients With Steroid-Refractory Acute Graft Versus Host Disease (SR-GVHD) Involving The Liver And Gut: Results Of A Randomized, Placebo-Controlled, Multicenter Phase III Trial In GVHD

✍ P.J. Martin; J.P. Uberti; R.J. Soiffer; H. Klingemann; E.K. Waller; A.S. Daly; R 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Efficacy and Safety of Ex Vivo Cultured

Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study

✍ Vinod K. Prasad; Kenneth G. Lucas; Gary I. Kleiner; Julie An M. Talano; David Ja 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 291 KB